News & Updates

Show Multimedia Only

Aspirin may improve survival in PIK3CA-mutated colon cancer

06 Oct 2024 by

Adjuvant treatment with aspirin appears to provide some protection in patients with resected, PIK3CA-mutant stage II and III colon cancer, demonstrating a clinically significant improvement (43 percent) in disease-free survival (DFS), suggests a study presented at ESMO Congress 2024.

Aspirin may improve survival in PIK3CA-mutated colon cancer

06 Oct 2024

Sequential chemoradiotherapy on par with IC+CCRT for locoregionally advanced NPC

05 Oct 2024 by

Among patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC), treatment with a sequential chemoradiotherapy (SCRT) regimen is noninferior to the induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) protocol in terms of 3-year failure-free survival (FFS), results of a phase III trial have shown.

Sequential chemoradiotherapy on par with IC+CCRT for locoregionally advanced NPC

05 Oct 2024

Which factors predict survival in lenvatinib-treated RR-DTC?

04 Oct 2024

Patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC) with good ECOG* performance status and radioactive iodine (RAI) avidity benefit the most from treatment with lenvatinib, a study has shown. Moreover, the only independent predictor of survival after treatment initiation is objective response.

Which factors predict survival in lenvatinib-treated RR-DTC?

04 Oct 2024

Survivors of childhood cancer at risk of stress, low QOL

04 Oct 2024 by

Some childhood cancer survivors (CCS) may experience psychological distress and have low health-related quality of life (HRQOL) after completing their cancer treatments, suggests a Singapore study.

Survivors of childhood cancer at risk of stress, low QOL

04 Oct 2024

Wearable device-based exercise intervention improves activity levels after lung cancer surgery

02 Oct 2024

In patients who are undergoing a surgical procedure for lung cancer, perioperative exercise interventions using wearable devices may help increase physical activity and improve dyspnoea after the procedure when compared with usual care, according to a study.

Wearable device-based exercise intervention improves activity levels after lung cancer surgery

02 Oct 2024

MASLD, MetALD tied to increased cancer risk

28 Sep 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) may predispose affected individuals to liver and gastrointestinal cancers, as reported in a study.

MASLD, MetALD tied to increased cancer risk

28 Sep 2024

Sintilimab plus bevacizumab shows therapeutic potential in ovarian clear cell carcinoma

27 Sep 2024

In the treatment of patients with relapsed or persistent ovarian clear cell carcinoma, the combination of sintilimab plus bevacizumab has demonstrated promising antitumour activity and manageable safety in the phase II INOVA trial.

Sintilimab plus bevacizumab shows therapeutic potential in ovarian clear cell carcinoma

27 Sep 2024

Serum S-adenosylhomocysteine linked to HCC survival

26 Sep 2024

In patients with hepatocellular carcinoma (HCC), higher serum S-adenosylhomocysteine (SAH) concentrations may contribute to a shorter survival, regardless of the genetic variants of one-carbon metabolism key enzyme, according to a study.

Serum S-adenosylhomocysteine linked to HCC survival

26 Sep 2024

$Nanvuranlat confers PFS gains in advanced, refractory biliary tract cancer$

Nanvuranlat confers PFS gains in advanced, refractory biliary tract cancer

26 Sep 2024

The investigational L-type amino acid transporter 1 inhibitor nanvuranlat has an acceptable safety profile and is associated with prolonged progression-free survival (PFS) in patients with advanced and refractory biliary tract cancer when used in later-line treatment settings, according to the results of a phase II study.

Nanvuranlat confers PFS gains in advanced, refractory biliary tract cancer

26 Sep 2024

Ultraprocessed food intake ups death risk in people with cancer history

25 Sep 2024

Regular consumption of ultraprocessed food (UPF) among individuals with a history of cancer appears to increase the risk of mortality, suggests a study.

Ultraprocessed food intake ups death risk in people with cancer history

25 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

Aspirin may improve survival in PIK3CA-mutated colon cancer

Aspirin may improve survival in PIK3CA-mutated colon cancer

Sequential chemoradiotherapy on par with IC+CCRT for locoregionally advanced NPC

Sequential chemoradiotherapy on par with IC+CCRT for locoregionally advanced NPC

Which factors predict survival in lenvatinib-treated RR-DTC?

Which factors predict survival in lenvatinib-treated RR-DTC?

Survivors of childhood cancer at risk of stress, low QOL

Survivors of childhood cancer at risk of stress, low QOL

Wearable device-based exercise intervention improves activity levels after lung cancer surgery

Wearable device-based exercise intervention improves activity levels after lung cancer surgery

MASLD, MetALD tied to increased cancer risk

MASLD, MetALD tied to increased cancer risk

Sintilimab plus bevacizumab shows therapeutic potential in ovarian clear cell carcinoma

Sintilimab plus bevacizumab shows therapeutic potential in ovarian clear cell carcinoma

Serum S-adenosylhomocysteine linked to HCC survival

Serum S-adenosylhomocysteine linked to HCC survival

Nanvuranlat confers PFS gains in advanced, refractory biliary tract cancer

Nanvuranlat confers PFS gains in advanced, refractory biliary tract cancer

Ultraprocessed food intake ups death risk in people with cancer history

Ultraprocessed food intake ups death risk in people with cancer history